UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
FORM 10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 1994
PART I--REGISTRANT INFORMATION
Columbia Laboratories, Inc.
2665 South Bayshore Drive
Miami, Florida 33133
PART II--RULES 12B-25(B) AND (C)
The reasons described in Part III of this form could not be eliminated
without unreasonable effort or expense. The subject annual report on Form 10-K
will be filed on or before April 17, 1995.
PART III--NARRATIVE
The Company was not able to complete the preparation of the Form 10-K on a
timely basis because the Company has been devoting a significant amount of its
time and resources towards negotiations in respect of a transaction which
management believes will have a significant impact on the Company, including its
current financial position.
PART IV--OTHER INFORMATION
(1) Margaret J. Roell
Vice President--Finance and Administration
Chief Financial Officer
(305) 860-1670
(2) Yes
(3) No
Columbia Laboratories, Inc. has caused this notification to be signed on
its behalf by the undersigned hereunto duly authorized.
/s/_Margaret J. Roell_________________
Vice President--Finance and
Administration
Chief Financial Officer
Dated March 30, 1995